. Author manuscript; available in PMC: 2022 Oct 1.

Published in final edited form as: Addiction. 2021 Apr 6;116(10):2790–2800. doi: 10.1111/add.15487

Table 4.

Timing of identification of other substance use disorders among 10,405 youth who experienced an opioid-related complication.

Diagnosis	Total^a N (% of all individuals with identified substance use)	Identified at time of initial prescription or during 6 preceding months^a N (row %)	Identified during 12 months following initial prescription^a N (row %)
Any substance use disorder (excluding opioid use disorder)	7,618 (100.0%)	2,208 (29.0%)	5,410 (71.0%)
Alcohol use disorder	2,546 (33.4%)	448 (17.6%)	2,098 (82.4%)
Cannabis use disorder	2,514 (33.0%)	447 (17.8%)	2,067 (82.2%)
Nicotine use disorder	3,289 (43.2%)	1,145 (34.8%)	2,144 (65.2%)
Other non-opioid substance use disorder	5,751 (75.5%)	904 (15.7%)	4,847 (84.3%)

^a.

Throughout, individuals could be counted in multiple rows if they had multiple substance use disorders (e.g., an alcohol use disorder and a cannabis use disorder).